Optimal construction of non-immune scFv phage display libraries from mouse bone marrow and spleen established to select specific scFvs efficiently binding to antigen

Biochemical and Biophysical Research Communications
Takayuki OkamotoYasuo Tsutsumi

Abstract

Monoclonal antibodies (MAbs) are widely applied in basic research, medicine, and the pharmaceutical industry. Recently, applications and generations of MAbs have been increasingly attracting attention in many research areas since MAbs could be produced in large quantities with the development of genetic technology and antibody engineering. On the other hand, in recent years, phage display system has been developed for high-throughput isolation and generation of novel MAbs that have high affinity with various antigens. This technology is capable of constructing "Library" containing billions of phage repertoires displaying various antibody fragments, and rapid selection of a specific MAb from this phage library. Additionally, this technology has a great advantage that MAbs can be generated without immunization to animals. However, there are still relatively few reports confirming that useful MAbs can be derived from non-immune antibody libraries. The latter, as undertaken by current methods, seem unable to achieve the high quality required to produce useful MAbs for any desired antigen because cloning of antibody gene from non-immune donors is inefficient. This problem is caused by the fact that their RT-PCR primer sets, PCR cond...Continue Reading

References

Feb 1, 1978·European Journal of Immunology·G KöhlerM J Shulman
Mar 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·W GerhardH Koprowski
Apr 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·H GramA S Kang
Aug 15, 1991·Nature·T ClacksonG Winter
Mar 21, 1998·Current Opinion in Biotechnology·A D Griffiths, A R Duncan
Jun 29, 1999·Nature Biotechnology·P S Chowdhury, I Pastan
Feb 6, 2002·Journal of Molecular Biology·Steffen GoletzUwe Karsten
Feb 14, 2003·The New England Journal of Medicine·Filip BaertPaul Rutgeerts
Apr 1, 2003·Nature Biotechnology·Yoko YamamotoTadanori Mayumi
Nov 5, 2003·Gastroenterology·Chinyu G Su, Gary R Lichtenstein
Mar 5, 2004·Expert Opinion on Biological Therapy·Maria G Russeva, Gregory P Adams

❮ Previous
Next ❯

Citations

Jul 5, 2006·Biological & Pharmaceutical Bulletin·Sunao ImaiShin-ichi Tsunoda
Apr 8, 2010·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Takuya YamashitaKazuo Maruyama
Nov 17, 2012·BMC Biotechnology·Rajesh KumarKalpana Luthra
Jan 23, 2016·Advanced Pharmaceutical Bulletin·Ali Akbar AlizadehSiavoush Dastmalchi
Sep 8, 2010·Veterinary Immunology and Immunopathology·Andrea BraganzaNicola J Mason
Jan 23, 2010·Journal of Immunological Methods·R SommavillaD Neri
Jan 17, 2009·Journal of Bioscience and Bioengineering·Yoichi KumadaShigeo Katoh
May 21, 2015·Protein Engineering, Design & Selection : PEDS·Keyu LiAnna M Wu
Jun 9, 2006·Biochemical and Biophysical Research Communications·Maki KawamuraShin-ich Tsunoda
Sep 20, 2005·Biochemical and Biophysical Research Communications·Gertrudis RojasJorge V Gavilondo
Aug 30, 2011·Biotechnology Advances·Mohammad Reza SafarnejadStefan Schillberg
Dec 9, 2016·Journal of Occupational and Environmental Medicine·Guang-Hui ZhangWeidong Wu
Feb 9, 2019·Preparative Biochemistry & Biotechnology·Samira Pourtaghi-AnvarianSiavoush Dastmalchi
Jun 26, 2009·Molecular Biology Reports·Maneerat KoohapitagtamTheerapol Sirinarumitr
Apr 13, 2017·Frontiers in Microbiology·Abdullah F U H SaeedShihua Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Antibody Repertoire Diversity

Antibody repertoire diversity and its role during natural infection is a prerequisite for molecular and structural elucidation of functionally protective immunity. Discover the latest insights into antibody diversity here.